Diagnostic Value of Serological Assays in Pediatric Inflammatory Bowel Disorders

Background: Pediatric studies reported that the combined use of the anti-neutrophil cytoplasm autoantibodies (ANCA) and the anti-Saccharomyces cerevisiae mannan antibodies (ASCA) may be a specific useful noninvasive test in the diagnosis of inflammatory bowel diseases (IBD). Aims: To evaluate the diagnostic accuracy of ANCA and ASCA in children with suspected IBD, and to see whether different commercially available assays (indirect immunofluorescence vs. ELISA) agree well enough in terms of analytical performance. Patients and Methods: Sixty-nine children (30 males, 39 females, age range 2–18 years) with suspicion of IBD entered the study. Before colonoscopy, a blood sample was also drawn to assess ASCA and ANCA. Results: A diagnosis of IBD was established in 47 patients; the remainder had infective or other causes of colitis. For ulcerative colitis, the association ASCA–/ANCA+ had 70% sensitivity and 86% specificity, with a positive predictive value of 82%. The association ASCA+/ANCA– had 86% sensitivity and 93% specificity for Crohn’s disease, with a positive predictive value of 75%. Conclusion: Although more experience is needed to state the diagnostic power of serologic assay, determination of ANCA and ASCA in IBD children may help both in distinguish these conditions from other entitiesand ulcerative colitis from Crohn’s disease, particularly in doubtful cases.

[1]  G. Sebastiani,et al.  [Antineutrophil cytoplasmic antibodies]. , 2011, Reumatismo.

[2]  N. Shepherd,et al.  What are the Controversies in Histopathological Diagnosis , 2008 .

[3]  A. Darzi,et al.  Diagnostic Precision of Anti-Saccharomyces cerevisiae Antibodies and Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease , 2006, The American Journal of Gastroenterology.

[4]  V. Autio,et al.  Elevated serum anti‐I2 and anti‐OmpW antibody levels in children with IBD , 2006, Inflammatory bowel diseases.

[5]  Richard E Thompson,et al.  Indeterminate colitis: A significant subgroup of pediatric IBD , 2006, Inflammatory bowel diseases.

[6]  R. Sandler,et al.  Positive and Negative Predictive Values: Use of Inflammatory Bowel Disease Serologic Markers , 2006, The American Journal of Gastroenterology.

[7]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[8]  A. Sodano,et al.  Combined Use of Noninvasive Tests is Useful in the Initial Diagnostic Approach to a Child with Suspected Inflammatory Bowel Disease , 2006, Journal of pediatric gastroenterology and nutrition.

[9]  J. Sellin,et al.  Clinical Indications of the Use of Antineutrophil Cytoplasmic Antibodies and Anti‐Saccharomyces cerevisiae Antibodies in the Evaluation of Inflammatory Bowel Disease at an Academic Medical Center , 2005, Inflammatory bowel diseases.

[10]  Y. Elitsur,et al.  The Diagnostic Accuracy of Serologic Markers in Children With IBD: The West Virginia Experience , 2005, Journal of clinical gastroenterology.

[11]  A. Bousvaros,et al.  Serologic Testing with ANCA, ASCA, and Anti-OmpC in Children and Young Adults with Crohn's Disease and Ulcerative Colitis: Diagnostic Value and Correlation with Disease Phenotype , 2004, The American Journal of Gastroenterology.

[12]  J. Croffie,et al.  Comparison of Serological Markers of Inflammatory Bowel Disease with Clinical Diagnosis in Children , 2004, Inflammatory bowel diseases.

[13]  W. Sandborn.  Serologic markers in inflammatory bowel disease: state of the art. , 2004, Reviews in gastroenterological disorders.

[14]  J. Seo,et al.  [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease]. , 2003, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[15]  O. Eremin,et al.  Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). , 2003, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[16]  M. Camilleri,et al.  Fecal Lactoferrin Is a Sensitive and Specific Marker in Identifying Intestinal Inflammation , 2003, American Journal of Gastroenterology.

[17]  O. Dewit,et al.  Serological markers in inflammatory bowel diseases. , 2003, Best practice & research. Clinical gastroenterology.

[18]  S. Schwarzenberg,et al.  Role of Serology and Routine Laboratory Tests in Childhood Inflammatory Bowel Disease , 2002, Inflammatory bowel diseases.

[19]  R. Baldassano,et al.  Inflammatory bowel disease in children 5 years of age and younger , 2002, American Journal of Gastroenterology.

[20]  A. Šedivá,et al.  Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. , 2002, Clinical immunology.

[21]  A. Zinsmeister,et al.  Evaluation of Serologic Disease Markers in a Population-Based Cohort of Patients with Ulcerative Colitis and Crohn's Disease , 2001, Inflammatory bowel diseases.

[22]  S. Targan,et al.  Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[23]  S. Targan,et al.  Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. , 1998, Gastroenterology.

[24]  P. Jacquinot,et al.  Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.

[25]  Y. Yoshida,et al.  [Indeterminate colitis]. , 1994, Ryoikibetsu shokogun shirizu.

[26]  G. Bodemar,et al.  Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. , 1993, Gut.

[27]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[28]  S. Targan,et al.  A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. , 1990, The Journal of allergy and clinical immunology.